1 August, 2026

When Heart Surgery Is Too Risky: Can Advanced Angioplasty Still Be an Option?

For some people with severe coronary artery disease, treatment is relatively straightforward. A blockage is identified, the overall health of the patient is good, and the cardiology team can choose between medicines, angioplasty or bypass surgery based primarily on the coronary anatomy.

But not every heart patient fits into this category.

What happens when a patient is 80 years old?

What if the kidneys are already functioning poorly?

What if the heart’s pumping capacity is severely reduced?

What if the patient has advanced lung disease, cancer, previous bypass surgery or several medical conditions at the same time?

These patients are often described as high-risk cardiac patients.

Being high-risk does not automatically mean that treatment is impossible. It means the decision has to be much more individualized.

Modern interventional cardiology has expanded the range of patients who can potentially be considered for catheter-based coronary treatment. Advanced angioplasty, intravascular imaging, calcium-modification techniques, CTO intervention and carefully planned complex PCI may provide an alternative in selected patients where conventional surgery would carry substantial risk.

The important principle is simple:

High risk does not necessarily mean no option. But every option must be weighed carefully against its potential benefit and risk.

Current coronary guidelines emphasize individualized, patient-centered decision-making when choosing between medical treatment, PCI and bypass surgery, particularly in patients with complex coronary disease or significant additional health conditions.

What Is a High-Risk Heart Patient?

There is no single definition that describes every high-risk coronary patient.

Risk usually results from a combination of the patient’s heart condition, coronary anatomy, age and other medical illnesses.

A patient may be considered higher risk because of:

• Advanced age
• Frailty
• Severe coronary artery disease
• Multiple blocked coronary arteries
• Left-main coronary disease
• Chronic total occlusion
• Severe coronary calcification
• Previous bypass surgery
• Previous failed angioplasty
• Multiple previous stents
• Reduced heart pumping function
• Heart failure
• Chronic kidney disease
• Dialysis
• Chronic lung disease
• Cancer
• Diabetes
• Previous stroke
• Anaemia
• High bleeding risk
• Multiple medical conditions occurring together

Some patients may have both high clinical risk and highly complex coronary anatomy, making treatment planning especially challenging.

This is where experience in complex coronary intervention becomes important.

Why Can Heart Surgery Become High Risk?

Coronary artery bypass grafting remains an important and sometimes preferred treatment for complex coronary artery disease.

However, an operation places significant physiological stress on the body.

A patient who is relatively young with good kidney, lung and heart function may tolerate surgery very differently from an elderly patient with kidney failure, severe lung disease and a weak heart.

Surgical risk can increase because of:

• Frailty
• Advanced age
• Poor kidney function
• Severe lung disease
• Very poor heart pumping function
• Previous open-heart surgery
• Cancer treatment
• Previous stroke
• Extensive disease of the aorta
• Severe vascular disease
• Malnutrition
• Multiple chronic illnesses

For certain patients, the expected risk of open surgery may therefore influence whether a less invasive revascularization strategy should be considered.

This does not mean PCI is automatically superior to surgery.

It means the cardiologist and cardiac surgeon need to determine which strategy offers the best balance between procedural safety, completeness of treatment, durability and expected benefit.

What Is High-Risk Angioplasty?

High-risk angioplasty, often referred to as complex or high-risk PCI, describes coronary intervention performed in patients whose clinical condition, coronary anatomy—or both—make routine angioplasty more challenging.

During PCI, an interventional cardiologist introduces thin catheters through an artery, generally from the wrist or groin, and advances them toward the coronary arteries.

The blockage can then be treated using balloons, coronary stents and, where necessary, specialized equipment.

High-risk PCI may involve treatment of:

• Left-main coronary artery disease
• Complex bifurcation disease
• Multiple coronary arteries
• Heavily calcified arteries
• Long coronary lesions
• Chronic total occlusions
• Degenerated bypass grafts
• Native coronary arteries after CABG
• Previously stented arteries
• Patients with significantly reduced heart function

Advances in intravascular imaging and complex PCI techniques have increased the ability to treat coronary anatomy that historically would have been extremely difficult using catheter-based intervention.

1. Angioplasty in Elderly Patients

One of the most common questions families ask is:

“Is my father or mother too old for angioplasty?”

There is no single age beyond which angioplasty becomes automatically impossible.

A healthy and independent 82-year-old may have a completely different risk profile from a frail 72-year-old with advanced kidney disease, severe lung disease and previous strokes.

Therefore, chronological age alone should not determine treatment.

Doctors may look at:

• Frailty
• Mobility
• Cognitive function
• Kidney function
• Lung function
• Heart pumping capacity
• Bleeding risk
• Other medical illnesses
• Ability to recover after treatment
• Expected quality-of-life improvement

Modern management of elderly coronary patients increasingly emphasizes biological health and frailty rather than age alone.

Why PCI may sometimes be considered

Angioplasty avoids opening the chest and can often be performed through a small arterial puncture.

For selected elderly patients who have symptomatic coronary disease but substantial surgical risk, PCI may therefore be considered as part of an individualized treatment strategy.

However, the goal is not simply to perform a procedure because it is technically possible.

Doctors must determine whether restoring blood flow is likely to improve symptoms, prevent clinically important events or meaningfully improve the patient’s overall condition.

2. Angioplasty in Patients With Kidney Disease

Kidney disease creates an important challenge in coronary intervention.

The kidneys help remove many substances from the bloodstream, and patients with chronic kidney disease already have reduced renal reserve.

Coronary angiography and angioplasty normally require contrast material to visualize the coronary arteries.

In patients with poor kidney function, the cardiology team must therefore pay particular attention to kidney protection and minimizing unnecessary contrast exposure.

The 2024 KDIGO chronic kidney disease guideline specifically addresses patients with CKD and ischemic heart disease and recognizes the need to carefully balance cardiovascular treatment with kidney-related risk.

Can a patient with renal failure still undergo angioplasty?

Potentially, yes.

Kidney disease is not automatically a contraindication to coronary angiography or PCI.

The decision depends on factors such as:

• Severity of kidney dysfunction
• Whether the patient is already on dialysis
• Urgency of the cardiac condition
• Complexity of the coronary disease
• Amount of contrast expected
• Blood pressure and hydration status
• Heart function
• Other medications
• Overall benefit expected from revascularization

Contrast-minimization strategies

In selected patients, experienced interventional teams may plan the procedure specifically to reduce contrast exposure.

This may involve careful pre-procedure planning and the use of intravascular imaging where appropriate.

The principle is not simply:

“The kidneys are weak, so angioplasty cannot be done.”

Instead, the heart risk and kidney risk need to be considered together.

3. Angioplasty in Patients With Heart Failure or Low Ejection Fraction

Another challenging group includes patients whose heart pumping function has become severely weakened.

The ejection fraction, or EF, is one measurement used to assess how effectively the left ventricle pumps blood.

When heart function is significantly reduced, procedures can become more challenging because the heart may have less reserve to tolerate temporary changes in blood flow during complex PCI.

Patients may present with:

• Breathlessness
• Extreme fatigue
• Swelling of the legs
• Recurrent hospital admissions
• Low blood pressure
• Reduced exercise capacity
• Severe coronary artery disease

When a patient develops reduced left ventricular function or clinical heart failure in association with chronic coronary disease, coronary anatomy may need to be assessed to determine whether potentially useful revascularization is present.

However, an important distinction must be made:

Finding coronary blockages in a patient with heart failure does not automatically mean that stenting those blockages will improve survival or restore heart function.

For example, the REVIVED-BCIS2 trial found that routine PCI added to optimal medical therapy did not reduce death or heart-failure hospitalization compared with optimal medical therapy alone in the particular population studied with severe ischemic left ventricular dysfunction.

Therefore, the decision to perform high-risk PCI in someone with poor EF should be based on the entire clinical picture rather than EF alone.

4. Angioplasty in Patients With Severe Lung Disease

Patients with chronic lung disease can present another difficult treatment decision.

Conditions such as severe COPD, interstitial lung disease or chronic respiratory insufficiency may increase the complexity of major surgery and recovery.

These patients may already have:

• Low oxygen levels
• Breathlessness
• Reduced exercise capacity
• Pulmonary hypertension
• Difficulty tolerating prolonged ventilation
• General frailty

At the same time, coronary artery disease may further worsen exercise tolerance and breathlessness.

The first challenge is determining how much of the patient’s symptoms are coming from the lungs and how much are coming from the heart.

If significant coronary disease is contributing to the clinical problem and surgery is considered particularly high risk, catheter-based treatment may sometimes be evaluated.

This requires careful coordination between cardiology, pulmonology, anaesthesia and other specialists when necessary.

5. Angioplasty in Patients With Cancer

Cancer and heart disease increasingly coexist because many people are living longer with and after cancer.

A patient undergoing cancer treatment may simultaneously develop coronary artery disease or an acute heart attack.

Cancer patients require especially individualized cardiovascular care because treatment decisions may be influenced by:

• Type and stage of cancer
• Expected cancer prognosis
• Chemotherapy
• Radiotherapy
• Planned surgery
• Platelet count
• Anaemia
• Bleeding risk
• Risk of blood clots
• Need for antiplatelet medicines after stenting

The ESC cardio-oncology guideline emphasizes multidisciplinary cardiovascular assessment before, during and after cancer treatment, particularly for higher-risk patients.

Can cancer patients receive a coronary stent?

In appropriate situations, yes.

Cancer itself does not automatically exclude someone from coronary angiography or PCI.

However, the treatment plan may need discussion between the interventional cardiologist and oncology team.

For example, the doctors may need to consider whether upcoming cancer surgery could conflict with antiplatelet medication required after coronary stenting.

The decision must therefore balance:

Heart risk + cancer treatment + bleeding risk + expected overall benefit.

6. Angioplasty After Previous Bypass Surgery

A patient who has already undergone CABG may later develop recurrent coronary problems.

These may include:

• Progression of disease in the original coronary arteries
• Narrowing of a bypass graft
• Degeneration of a vein graft
• Complete blockage of a native artery
• New disease in another coronary vessel

Redo bypass surgery can be substantially more complicated in some patients, especially when accompanied by older age and other illnesses.

Advanced PCI may therefore be considered in selected post-CABG patients.

Possible strategies include treating:

• The native coronary artery
• The bypass graft
• A chronic total occlusion
• Previously stented segments

The decision depends heavily on individual anatomy.

7. Chronic Total Occlusion in High-Risk Patients

A chronic total occlusion, or CTO, is an artery that has been completely blocked for an extended period.

CTOs are among the most technically demanding coronary lesions.

Modern CTO PCI can use specialized guidewires, microcatheters and multiple crossing strategies to attempt reopening the vessel.

However:

Not every completely blocked artery needs to be opened.

Before considering CTO PCI, doctors assess:

• Symptoms
• Heart muscle supplied by the artery
• Evidence of ischemia
• Heart function
• Other functioning arteries
• Previous bypass grafts
• Procedural complexity
• Likelihood of successful treatment
• Overall clinical benefit

Technical capability should never replace appropriate patient selection.

8. Heavily Calcified Coronary Arteries

Coronary arteries can become heavily calcified, particularly in older adults, people with diabetes and those with long-standing kidney disease.

Calcium can make routine balloon expansion difficult and may prevent a coronary stent from expanding adequately.

Modern complex PCI therefore includes specialized methods to modify calcified plaque before stent implantation.

Depending on the type of calcification and lesion anatomy, the interventional cardiologist may use specialized balloon or plaque-modification technologies.

The goal is to create an artery that can safely accept and fully expand the stent.

The Role of IVUS and OCT in High-Risk Angioplasty

One of the major developments in complex coronary intervention has been the increasing use of intravascular imaging.

Two important technologies are:

IVUS – Intravascular Ultrasound

A miniature ultrasound catheter provides images from inside the coronary artery.

OCT – Optical Coherence Tomography

OCT provides very high-resolution images of the inside of the artery using light-based imaging.

These technologies can help cardiologists understand:

• Vessel size
• Plaque distribution
• Calcium
• Stent expansion
• Stent positioning
• Mechanisms of previous stent failure

In complex disease, this information can sometimes provide much greater detail than angiography alone.

High Risk Does Not Mean Angioplasty Is Always the Answer

This is an extremely important point.

The purpose of advanced interventional cardiology is not to perform angioplasty on every patient considered too high-risk for surgery.

Sometimes the best treatment is medication.

Sometimes bypass surgery remains the better option despite increased risk.

Sometimes a combination of treatments may be appropriate.

And occasionally the procedural risk of intervention may outweigh its likely benefit.

Current guidelines therefore emphasize shared decision-making and individualized selection of the revascularization strategy.

The objective is not:

“Can we technically place a stent?”

The better question is:

“Will treating this blockage provide meaningful benefit to this patient?”

How Is a High-Risk Patient Evaluated Before Angioplasty?

A detailed assessment may include:

Clinical evaluation

The cardiologist assesses symptoms, medical history, previous procedures and overall health.

ECG

Helps identify rhythm problems, previous heart attacks or active ischemic changes.

Echocardiography

Provides information about heart pumping function, valves and pressures within the heart.

Blood tests

Particular attention may be paid to:

• Kidney function
• Haemoglobin
• Platelet count
• Blood sugar
• Electrolytes

Coronary angiography

Shows the location, severity and complexity of coronary blockages.

Previous records

Patients with complex disease should bring previous:

• Angiograms
• Angioplasty reports
• Stent details
• CABG reports
• CT scans
• Echocardiograms
• Hospital discharge summaries

Understanding what has previously been done can be essential when planning another intervention.

When Might Advanced Angioplasty Be Considered?

Complex PCI may be evaluated when a patient has significant coronary disease associated with problems such as:

• Persistent angina despite medical therapy
• Acute coronary syndrome
• Certain heart attacks
• Severe limiting symptoms
• Complex coronary disease
• Previous CABG with recurrent disease
• Chronic total occlusion
• Multiple previous interventions
• High predicted surgical risk

The decision should be based on detailed assessment rather than one factor alone.

What Are the Risks?

Calling a procedure “minimally invasive” does not mean it is risk-free.

Complex coronary intervention can involve complications such as:

• Bleeding
• Blood-vessel injury
• Kidney injury
• Coronary artery damage
• Heart attack
• Abnormal heart rhythms
• Stroke
• Emergency surgery
• Rarely, death

Risk varies enormously from one patient to another.

This is why high-risk PCI requires careful planning, appropriate facilities and an experienced interventional team.

Patients and families should understand both the expected benefit and the potential risk before deciding on treatment.

Hope for Patients Who Have Been Told Surgery Is High Risk

One of the most difficult situations for a patient and family is being told:

“Surgery would be very high risk.”

It can easily be interpreted as:

“Nothing else can be done.”

Those two statements are not always the same.

Some high-risk patients may still have options including:

• Optimized medical therapy
• Advanced coronary angioplasty
• CTO PCI
• Image-guided PCI
• Treatment of calcified coronary disease
• Structural heart intervention
• Hybrid treatment strategies
• Carefully selected surgery

The right approach depends entirely on the individual patient.

Hope for No Option!

Modern interventional cardiology can sometimes provide treatment possibilities for patients previously considered extremely difficult to treat.

But the aim should always be appropriate intervention—not intervention at any cost.

High-Risk Coronary Intervention in Chennai

Patients with complicated coronary disease may benefit from evaluation by an interventional cardiologist experienced in managing high-risk anatomy and multiple medical conditions.

This can be particularly important for patients with:

• Advanced age
• Kidney failure
• Lung disease
• Cancer
• Heart failure
• Low ejection fraction
• Previous bypass surgery
• Chronic total occlusion
• Severe coronary calcification
• Multiple previous stents
• High surgical risk

The treatment strategy should consider the patient’s entire health—not only the angiogram.

Dr. Dhamodaran K

Interventional Cardiologist

Dr. Dhamodaran K is an experienced interventional cardiologist with more than 24 years of experience in interventional cardiology.

He completed his DM in Cardiology from Madras Medical College and Research Institute under Dr. MGR Medical University and has extensive experience in advanced coronary and structural heart interventions.

His clinical focus includes evaluating complex and high-risk cardiac patients and determining whether advanced catheter-based treatment may provide an alternative where conventional treatment options are limited.

Hope for No Option!

Advanced Angioplasty and TAVR for Heart Patients with High Surgical Risk

Consultation in Chennai

Sidharam Multispeciality Clinic

Old #2, New #4,
Canal Bank Road, Gandhi Nagar,
Adyar, Chennai, Tamil Nadu – 600020

Working Hours
Monday – Thursday
06:00 PM – 09:00 PM

Apollo Hospitals, Greams Road

Chennai

Working Hours
Monday – Saturday
10:00 AM – 04:00 PM

Frequently Asked Questions

Is angioplasty safe for elderly patients?

Angioplasty can be performed in selected elderly patients, but safety depends on much more than age. Frailty, kidney function, heart function, bleeding risk, coronary anatomy and other medical conditions are considered before treatment.

Can angioplasty be performed if kidney function is poor?

Potentially, yes. Kidney disease does not automatically exclude PCI, but careful planning and strategies to limit kidney injury may be required.

Can a patient with 25% or 30% heart function undergo angioplasty?

Some patients with severely reduced heart function undergo PCI, but low EF alone does not determine whether angioplasty will be beneficial. Coronary anatomy, symptoms, heart-muscle viability, overall clinical condition and the expected benefit of revascularization must all be considered.

Can cancer patients undergo angioplasty?

Yes, when clinically appropriate. The cardiology and oncology teams may need to coordinate treatment because cancer therapy, planned surgery, platelet counts and bleeding risks can influence PCI planning.

Can patients with severe lung disease undergo angioplasty?

In selected patients, yes. If open-heart surgery carries substantial respiratory risk, catheter-based intervention may be evaluated depending on the heart condition and coronary anatomy.

Is angioplasty always better than bypass for high-risk patients?

No.

For some patients PCI is appropriate; for others CABG provides the better treatment; and some patients may be best treated with medication.

Individualized assessment is essential.

What if another hospital has said surgery is too risky?

A high surgical-risk assessment does not necessarily mean that another treatment is available, but complex cases can sometimes benefit from review by a heart team or interventional cardiologist experienced in advanced coronary procedures.

The Takeaway

Severe coronary artery disease becomes significantly more complicated when it occurs alongside advanced age, kidney failure, cancer, severe lung disease, heart failure, previous bypass surgery or multiple other illnesses.

But complex does not necessarily mean untreatable.

Modern cardiology provides several potential treatment strategies, ranging from intensive medical therapy to advanced angioplasty and surgery.

For high-risk patients, the most important step is not simply deciding whether a blockage can be opened.

It is determining:

Which treatment gives this individual patient the best balance of benefit, safety and quality of life?

That decision requires experience, careful planning and a truly individualized approach.

Medical Disclaimer: This article is intended for general educational purposes only and does not replace individualized medical assessment. Patients experiencing persistent or severe chest pain, sudden breathlessness, fainting, sweating or symptoms suggestive of a heart attack should seek emergency medical attention immediately.